R. Adams and D. Brambilla, Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease, N Engl J Med, vol.353, issue.26, pp.2769-2778, 2005.

M. Lee, S. Piomelli, S. Granger, S. Ler, S. Harkness et al., Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results, Blood, vol.108, issue.3, pp.847-852, 2006.
DOI : 10.1182/blood-2005-10-009506

D. Gallagher, A. Kutlar, F. Nichols, D. Bonds, and D. Brambilla, Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography, N Engl J Med, vol.339, issue.1, pp.5-11, 1998.

E. Vichinsky, Current issues with blood transfusions in sickle cell disease, Seminars in Hematology, vol.38, issue.1, pp.14-22, 2001.
DOI : 10.1016/S0037-1963(01)90056-3

F. Noizat-pirenne, D. Bachir, and P. Chadebech, Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease, Haematologica, vol.92, issue.12, pp.132-135, 2007.
DOI : 10.3324/haematol.12074

M. Bauer, J. Wiersum-osselton, M. Schipperus, J. Vandenbroucke, and E. Briet, Clinical predictors of alloimmunization after red blood cell transfusion, Transfusion, vol.96, issue.11, pp.2066-2071, 2007.
DOI : 10.1111/j.1537-2995.2006.00946.x

W. Rosse, D. Gallagher, and T. Kinney, Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease, Blood, vol.76, issue.7, pp.1431-1437, 1990.

S. Sarnaik, J. Schornack, and J. Lusher, The incidence of development of irregular red cell antibodies in patients with sickle cell anemia, Transfusion, vol.26, issue.3, pp.249-252, 1986.
DOI : 10.1046/j.1537-2995.1986.26386209381.x

J. Cox, E. Steane, G. Cunningham, and E. Frenkel, Risk of Alloimmunization and Delayed Hemolytic Transfusion Reactions in Patients With Sickle Cell Disease, Archives of Internal Medicine, vol.148, issue.11, pp.2485-2489, 1988.
DOI : 10.1001/archinte.1988.00380110115024

M. Murao and M. Viana, Risk factors for alloimmunization by patients with sickle cell disease, Braz J Med Biol Res, vol.38, issue.5, pp.675-682, 2005.

H. Schonewille, L. Van-de-watering, D. Loomans, and A. Brand, Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity, Transfusion, vol.7, issue.2, pp.250-256, 2006.
DOI : 10.1046/j.1537-2995.1994.34294143938.x

J. Higgins and S. Sloan, Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic responders, Blood, vol.112, issue.6, pp.2546-2553, 2008.
DOI : 10.1182/blood-2008-03-146415

B. Natukunda, H. Schonewille, C. Ndugwa, and A. Brand, Red blood cell alloimmunization in sickle cell disease patients in Uganda, Transfusion, vol.48, issue.1, pp.20-25, 2010.
DOI : 10.1111/j.1537-2995.2009.02435.x

A. Olujohungbe, I. Hambleton, L. Stephens, B. Serjeant, and G. Serjeant, Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom, British Journal of Haematology, vol.81, issue.3, pp.661-665, 2001.
DOI : 10.1056/NEJM199507273330402

B. Natukunda, A. Brand, and H. Schonewille, Red blood cell alloimmunization from an African perspective, Current Opinion in Hematology, vol.17, issue.6, pp.565-570, 2010.
DOI : 10.1097/MOH.0b013e32833ec54b

R. Gupta, D. Singh, B. Singh, and U. Rusia, Alloimmunization to red cells in thalassemics: Emerging problem and future strategies, Transfusion and Apheresis Science, vol.45, issue.2, pp.167-170, 2011.
DOI : 10.1016/j.transci.2011.07.014

E. Vichinsky, N. Luban, and E. Wright, Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial, Transfusion, vol.43, issue.9, pp.1086-1092, 2001.
DOI : 10.1046/j.1537-2995.1997.37497265339.x

M. Lasalle-williams, R. Nuss, and T. Le, Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME), Transfusion, vol.49, issue.8, pp.1732-1739, 2011.
DOI : 10.1111/j.1537-2995.2010.03045.x

W. Flegel, Molecular genetics of??RH and??its??clinical application, Transfusion Clinique et Biologique, vol.13, issue.1-2, pp.4-12, 2006.
DOI : 10.1016/j.tracli.2006.02.011

S. Urbaniak, Alloimmunity to??RhD in??humans, Transfusion Clinique et Biologique, vol.13, issue.1-2, pp.19-22, 2006.
DOI : 10.1016/j.tracli.2006.02.020

G. Daniels, G. Poole, and J. Poole, Partial D and weak D: can they be distinguished? Transfus Med Noizat-Pirenne F, Tournamille C. Relevance of RH variants in transfusion of sickle cell patients, Transfus Clin Biol, vol.1718, issue.24, pp.145-1465, 2007.
DOI : 10.1111/j.1365-3148.2006.00707.x

D. Vege, S. Halter-hipsky, and C. , often in linkage with ceAR, a new Rhce variant frequently found in African blacks DIIIa and DIII Type 5 are encoded by the same allele and are associated with altered RHCE*ce alleles: clinical implications, Blood. Westhoff CM Transfusion, vol.79450, issue.266, pp.4337-43421303, 1999.

L. Castilho, M. Rios, A. Rodrigues, J. Pellegrino, J. Saad et al., High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD, Transfusion Medicine, vol.20, issue.1, pp.49-55, 2005.
DOI : 10.1046/j.1537-2995.2001.41111413.x

C. Tournamille, N. Meunier-costes, and B. Costes, Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization, Transfusion, vol.49, issue.1, pp.13-19, 2010.
DOI : 10.1111/j.1537-2995.2009.02382.x

B. Faas, E. Beckers, and P. Wildoer, Molecular background of VS and weak C expression in blacks, Transfusion, vol.37, issue.1, pp.38-44, 1997.
DOI : 10.1046/j.1537-2995.1997.37197176949.x

C. Rouillac, P. Gane, J. Cartron, L. Pennec, P. Cartron et al., Molecular basis of the altered antigenic expression of RhD in weak D(Du) and RhC/e in RN phenotypes, Blood, vol.87, issue.11, pp.4853-4861, 1996.

M. Reid, J. Storry, and L. Sausais, DAK, a new low-incidence antigen in the Rh blood group system, Transfusion, vol.83, issue.10, pp.1394-1397, 2003.
DOI : 10.1046/j.1537-2995.1999.39111259.x

R. Anderson, S. Sosler, J. Kovach, P. Dechristopher, J. Squires et al., Delayed hemolytic transfusion reaction due to anti-Js(a) in an alloimmunized patient with a sickle cell syndrome A delayed hemolytic transfusion reaction due to anti-Cob Noizat-Pirenne F. [Immunohematologic characteristics in the Afro-caribbean population. Consequences for transfusion safety] Alloimmunization to platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3*0101 and HLA-DQB1*0201, Am J Clin Pathol. Transfusion. Transfus Clin Biol. Hum Immunol. Transfusion, vol.10825103446, issue.368, pp.658-661137, 1985.

C. Picard, C. Frassati, and A. Basire, immunization in a Southern European population, Transfusion, vol.40, issue.11, pp.2412-2417, 2009.
DOI : 10.1111/j.1537-2995.2009.02369.x
URL : https://hal.archives-ouvertes.fr/halshs-00637690

C. Hoppe, W. Klitz, E. Vichinsky, and L. Styles, HLA type and risk of alloimmunization in sickle cell disease, American Journal of Hematology, vol.49, issue.7, pp.462-464, 2009.
DOI : 10.1002/ajh.21442

J. Yu, S. Heck, and K. Yazdanbakhsh, Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models, American Journal of Hematology, vol.114, issue.8, pp.691-696, 2007.
DOI : 10.1002/ajh.20959

W. Bao, Y. J. Heck, S. Yazdanbakhsh, and K. , Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice, Blood, vol.113, issue.22, pp.5624-5627, 2009.
DOI : 10.1182/blood-2008-12-193748

W. Bao, H. Zhong, and X. Li, Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and ??-thalassemia major, American Journal of Hematology, vol.96, issue.12, pp.1001-1006, 2011.
DOI : 10.1002/ajh.22167

C. Dong, TH17 cells in development: an updated view of their molecular identity and genetic programming, Nature Reviews Immunology, vol.178, issue.5, pp.337-348, 2008.
DOI : 10.1038/nri2295

L. Yang, D. Anderson, and C. Baecher-allan, IL-21 and TGF-?? are required for differentiation of human TH17 cells, Nature, vol.282, issue.7202, pp.350-352, 2008.
DOI : 10.1038/nature07021

J. Hibbert, L. Hsu, and S. Bhathena, Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease, Exp Biol Med (Maywood), vol.230, issue.1, pp.68-74, 2005.

K. Bourantas, G. Dalekos, A. Makis, A. Chaidos, S. Tsiara et al., Acute phase proteins and interleukins in steady state sickle cell disease, European Journal of Haematology, vol.323, issue.suppl 3, pp.49-54, 1998.
DOI : 10.1111/j.1600-0609.1998.tb01060.x

M. Jison, P. Munson, and J. Barb, Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease, Blood, vol.104, issue.1, pp.270-280, 2004.
DOI : 10.1182/blood-2003-08-2760

J. Belcher, P. Marker, J. Weber, R. Hebbel, and G. Vercellotti, Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vasoocclusion, Blood, vol.96, issue.7, pp.2451-2459, 2000.

O. Platt, Sickle cell anemia as an inflammatory disease, Journal of Clinical Investigation, vol.106, issue.3, pp.337-338, 2000.
DOI : 10.1172/JCI10726

J. Hendrickson, T. Chadwick, J. Roback, C. Hillyer, and J. Zimring, Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells, Blood, vol.110, issue.7, pp.2736-2743, 2007.
DOI : 10.1182/blood-2007-03-083105

E. Trombetta and I. Mellman, CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO, Annual Review of Immunology, vol.23, issue.1
DOI : 10.1146/annurev.immunol.22.012703.104538

M. Yazer, D. Triulzi, B. Shaz, T. Kraus, and J. Zimring, Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?, Transfusion, vol.42, issue.6, pp.1070-1075, 2009.
DOI : 10.1111/j.1537-2995.2009.02116.x

J. Hendrickson, E. Hod, and J. Perry, Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease, Transfusion, vol.112, issue.2, pp.231-271, 2012.
DOI : 10.1111/j.1537-2995.2011.03255.x

E. Manci, C. Hillery, C. Bodian, Z. Zhang, G. Lutty et al., Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease, Blood, vol.107, issue.4, pp.1651-1658, 2006.
DOI : 10.1182/blood-2005-07-2839

N. Smith, E. Hod, S. Spitalnik, J. Zimring, and J. Hendrickson, Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis Transfusion in the absence of inflammation induces antigen specific tolerance to murine RBCs, Blood. Blood, vol.92119, issue.566, pp.2551-2555, 1998.

F. Gill, L. Sleeper, and S. Weiner, Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease, Blood, vol.86, issue.2, pp.776-783, 1995.

P. Walter, E. Fung, and D. Killilea, Oxidative stress and inflammation in iron-overloaded patients with ?-thalassaemia or sickle cell disease, British Journal of Haematology, vol.300, issue.2, pp.254-263, 2006.
DOI : 10.1016/S0140-6736(89)90264-X

L. Verduzco and D. Nathan, Sickle cell disease and stroke, Blood, vol.114, issue.25, pp.5117-5125, 2009.
DOI : 10.1182/blood-2009-05-220921

Z. Tatari-calderone, C. Minniti, and T. Kratovil, rs660 polymorphism in Ro52 (SSA1; TRIM 21) is a marker for age-dependent tolerance induction and efficiency of alloimmunization in sickle cell disease???, Molecular Immunology, vol.47, issue.1, pp.64-70, 2009.
DOI : 10.1016/j.molimm.2008.12.027

S. Patel, J. Hendrickson, and N. Smith, Alloimmunization against RBC or PLT antigens is independent of TRIM21 expression in a murine model, Molecular Immunology, vol.48, issue.6-7, pp.6-7909, 2011.
DOI : 10.1016/j.molimm.2010.12.017

S. Castellino, M. Combs, S. Zimmerman, P. Issitt, and R. Ware, Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance, British Journal of Haematology, vol.39, issue.1, pp.189-194, 1999.
DOI : 10.1046/j.1537-2995.1984.24685066805.x

G. Garratty, Autoantibodies induced by blood transfusion, Transfusion, vol.82, issue.3, pp.5-9, 2004.
DOI : 10.1002/art.501

B. Aygun, S. Padmanabhan, C. Paley, V. Chandrasekaran, P. Young et al., Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia? Transfusion, Transfusion, vol.4244, issue.651, pp.37-4367, 2002.

M. Lasalle-williams, R. Nuss, and T. Le, Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14-year experience from a single center (CME), Transfusion, vol.49, issue.8, pp.1732-1739, 2011.
DOI : 10.1111/j.1537-2995.2010.03045.x

J. Playfair and S. Marshall-clarke, Induction of Red Cell Autoantibodies in Normal Mice, Nature New Biology, vol.243, issue.128
DOI : 10.1038/newbio243213a0

R. Barker, K. Casswell, and C. Elson, Identification of murine erythrocyte autoantigens and cross-reactive rat antigens, Immunology, vol.78, issue.4, pp.568-573, 1993.

R. Barker, A. Hall, G. Standen, J. Jones, and C. Elson, Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia, Blood, vol.90, issue.7, pp.2701-2715, 1997.

R. Barker, C. Shen, C. Elson, A. Hall, F. Ward et al., T-cell specificity in murine autoimmune haemolytic anaemia induced by rat red blood cells Interleukin-10- mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen, Clin Exp Immunol. Blood, vol.129100, issue.7113, pp.208-2134529, 2002.

H. Chaplin, J. Zarkowsky, and H. , Combined Sickle Cell Disease and Autoimmune Hemolytic Anemia, Archives of Internal Medicine, vol.141, issue.8, pp.1091-1093, 1981.
DOI : 10.1001/archinte.1981.00340080127029

C. Proudfit, E. Atta, and N. Doyle, Hemolytic Transfusion Reaction After Preoperative Prophylactic Blood Transfusion for Sickle Cell Disease in Pregnancy, Obstetrics & Gynecology, vol.110, issue.Supplement, pp.471-474, 2007.
DOI : 10.1097/01.AOG.0000258784.61584.f5

N. Win, H. Doughty, P. Telfer, B. Wild, and T. Pearson, Hyperhemolytic transfusion reaction in sickle cell disease, Transfusion, vol.73, issue.3, pp.323-328, 2001.
DOI : 10.1054/blre.1999.0121

P. Milner, J. Squires, P. Larison, W. Charles, J. Krauss et al., Posttransfusion Crises in Sickle Cell Anemia, Southern Medical Journal, vol.78, issue.12, pp.1462-146938, 1985.
DOI : 10.1097/00007611-198512000-00016

M. Kalyanaraman, S. Heidemann, A. Sarnaik, K. Meert, and S. Sarnaik, Anti-s Antibody-Associated Delayed Hemolytic Transfusion Reaction in Patients With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, vol.21, issue.1
DOI : 10.1097/00043426-199901000-00016

C. Engelfriet, H. Reesink, and R. Fontao-wendel, Prevention and diagnosis of delayed haemolytic transfusion reactions, Vox Sang, vol.91, issue.4, pp.353-368, 2006.

Y. Liu, E. Masuda, M. Blank, K. Kirou, X. Gao et al., Cytokine-mediated regulation of activating and inhibitory Fc?? receptors in human monocytes, Journal of Leukocyte Biology, vol.77, issue.5, pp.767-776, 2005.
DOI : 10.1189/jlb.0904532

P. Chadebech, A. Habibi, and R. Nzouakou, Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death, Transfusion, vol.2007, issue.9, pp.1785-1792, 2009.
DOI : 10.1111/j.1537-2995.2009.02199.x

C. Liu, P. Marshall, I. Schreibman, A. Vu, W. Gai et al., Interaction between terminal complement proteins C5b-7 and anionic phospholipids, Molecular Immunology, vol.35, issue.6-7, pp.2297-2301, 1999.
DOI : 10.1016/S0161-5890(98)90851-3

G. Garratty, The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction?, Transfusion Medicine, vol.23, issue.6, pp.321-334, 2008.
DOI : 10.1111/j.1365-3148.2008.00891.x

K. Lang, P. Lang, and C. Bauer, Mechanisms of Suicidal Erythrocyte Death, Cellular Physiology and Biochemistry, vol.15, issue.5, pp.195-202, 2005.
DOI : 10.1159/000086406

E. Hod, C. Cadwell, and J. Liepkalns, Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions, Blood, vol.112, issue.3, pp.891-894, 2008.
DOI : 10.1182/blood-2008-01-132092

R. Davenport, R. Strieter, T. Standiford, and S. Kunkel, Interleukin-8 production in red blood cell incompatibility, Blood, vol.76, issue.12, pp.2439-2442, 1990.

R. Davenport and S. Kunkel, Cytokine Roles in Hemolytic and Nonhemolytic Transfusion Reactions, Transfusion Medicine Reviews, vol.8, issue.3, pp.157-168, 1994.
DOI : 10.1016/S0887-7963(94)70108-5

J. Jang, E. Hod, S. Spitalnik, and P. Frenette, CXCL1 and its receptor, CXCR2, mediate murine sickle cell vaso-occlusion during hemolytic transfusion reactions, Journal of Clinical Investigation, vol.121, issue.4, pp.1397-1401, 2011.
DOI : 10.1172/JCI45336DS1
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069787

B. Setty, S. Kulkarni, and M. Stuart, Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion, Blood, vol.99, issue.5, pp.1564-1571, 2002.
DOI : 10.1182/blood.V99.5.1564

C. Brumfield, J. Huddleston, L. Dubois, B. Harris, and J. , A delayed hemolytic transfusion reaction after partial exchange transfusion for sickle cell disease in pregnancy: a case report and review of the literature, Obstet Gynecol, vol.63, issue.3, pp.13-15, 1984.

D. Bowen, A. Devenish, J. Dalton, and P. Hewitt, and Anti-Fy5, Vox Sanguinis, vol.52, issue.1, pp.35-36, 1988.
DOI : 10.1111/j.1423-0410.1988.tb04685.x

J. Thornton and D. Sams, Preanesthesia transfusion and sickle cell anemia patients: case report and controversies, Spec Care Dentist, vol.13, issue.6, pp.254-257, 1993.

S. Syed, D. Sears, J. Werch, M. Udden, J. Milam et al., Case reports: delayed hemolytic transfusion reaction in sickle cell disease Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety, Am J Med Sci. Anaesthesia. Blood, vol.31260100, issue.9412, pp.175-181609, 1996.

P. Larson, M. Lukas, D. Friedman, and C. Manno, Delayed hemolytic transfusion reaction due to anti-Goa, an antibody against the low-prevalence Gonzales antigen, American Journal of Hematology, vol.83, issue.4, pp.248-250, 1996.
DOI : 10.1002/(SICI)1096-8652(199612)53:4<248::AID-AJH8>3.0.CO;2-Y

N. Win, H. New, E. Lee, J. De-la-fuente, K. King et al., Hyperhemolysis syndrome in sickle cell disease, Expert Review of Hematology, vol.2, issue.2, pp.1231-1238376, 1997.
DOI : 10.1586/ehm.09.2

D. Darbari, O. Castro, and J. Taylor, Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell Disease, Journal of the National Medical Association, vol.100, issue.8, pp.948-951, 2008.
DOI : 10.1016/S0027-9684(15)31410-3

U. Katz, A. Achiron, Y. Sherer, and Y. Shoenfeld, Safety of intravenous immunoglobulin (IVIG) therapy, Autoimmunity Reviews, vol.6, issue.4, pp.257-259, 2007.
DOI : 10.1016/j.autrev.2006.08.011

M. De-montalembert, M. Dumont, and C. Heilbronner, Delayed hemolytic transfusion reaction in children with sickle cell disease, Haematologica, vol.96, issue.6, pp.801-817, 2011.
DOI : 10.3324/haematol.2010.038307
URL : https://hal.archives-ouvertes.fr/inserm-00607864

C. Bachmeyer, M. J. Parrot, and A. , Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia, American Journal of Hematology, vol.85, issue.1, pp.91-92, 2010.
DOI : 10.1002/ajh.21578

D. Anstee, Red cell genotyping and the future of pretransfusion testing, Blood, vol.114, issue.2, pp.248-256, 2009.
DOI : 10.1182/blood-2008-11-146860

A. James, C. Hillyer, and B. Shaz, Demographic differences in estimated blood donor eligibility prevalence in the United States. Transfusion, 2011.

M. Masse, Universal leukoreduction of cellular and plasma components: process control and performance of the leukoreduction process, Transfusion Clinique et Biologique, vol.8, issue.3, pp.297-302, 2001.
DOI : 10.1016/S1246-7820(01)00119-7

B. Bryant, M. Bianchi, R. Wesley, D. Stroncek, and S. Leitman, Leukoreduction filtration of whole-blood units from sickle trait donors: effects of a metered citrate anticoagulant system, Transfusion, vol.26, issue.12, pp.2233-2241, 2007.
DOI : 10.1046/j.1365-2141.2003.04464.x

M. Reff, K. Carner, and K. Chambers, Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20, Blood, vol.83, issue.2, pp.435-445, 1994.

G. Francosalinas, H. Mai, and V. Jovanovic, TNF blockade abrogates the induction of T cell-dependent humoral responses in an allotransplantation model, Journal of Leukocyte Biology, vol.90, issue.2, pp.367-375, 2011.
DOI : 10.1189/jlb.0710392

A. Turhan, L. Weiss, N. Mohandas, B. Coller, and P. Frenette, Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm, Proceedings of the National Academy of Sciences, vol.99, issue.5, pp.3047-3051, 2002.
DOI : 10.1073/pnas.052522799

D. Tracey, L. Klareskog, E. Sasso, J. Salfeld, and P. Tak, Tumor necrosis factor antagonist mechanisms of action: A comprehensive review, Pharmacology & Therapeutics, vol.117, issue.2, pp.244-279, 2008.
DOI : 10.1016/j.pharmthera.2007.10.001

K. Wallace and J. Linden, Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease, Blood, vol.116, issue.23, pp.5010-5020, 2010.
DOI : 10.1182/blood-2010-06-290643

M. Ford and C. Larsen, Translating costimulation blockade to the clinic: lessons learned from three pathways, Immunological Reviews, vol.162, issue.1, pp.294-306, 2009.
DOI : 10.1111/j.1600-065X.2009.00776.x

A. Hall, L. Cairns, D. Altmann, R. Barker, and S. Urbaniak, Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice, Blood, vol.105, issue.5, pp.2175-2179, 2005.
DOI : 10.1182/blood-2004-04-1554

B. Veldhuisen, C. Van-der-schoot, and M. De-haas, Blood group genotyping: from patient to high-throughput donor screening, Vox Sanguinis, vol.48, issue.Suppl. 1, pp.198-206, 2009.
DOI : 10.1111/j.1423-0410.2009.01209.x